Hematoporphyrin Hydrochloride, identified by CAS number 17471-45-3, stands as a crucial compound in the realm of advanced scientific research, particularly within oncology. Its primary distinction lies in its demonstrable fluorescence effects, a property that has been extensively studied in both animal models and in vitro cellular experiments. This characteristic makes it an invaluable tool for researchers aiming to visualize cellular processes and therapeutic interactions.

The compound's utility extends beyond mere visualization. A significant application highlighted in research is its capacity to enhance the effectiveness of cancer cell killing when used in conjunction with laser technology. This synergistic approach offers a promising avenue for developing more potent anti-cancer strategies in experimental settings. Researchers are actively exploring how this interaction can lead to improved outcomes in cancer treatment research, aiming to harness its properties for targeted cell destruction.

Furthermore, extensive animal experimentation has confirmed that Hematoporphyrin Hydrochloride exhibits low toxicity. This safety profile is paramount for researchers, ensuring that experimental results are attributable to the compound's specific properties rather than adverse systemic effects. The adherence to rigorous quality standards, including USP, BP, EP, and FCC, further solidifies its position as a reliable and high-quality chemical for sensitive research applications. Companies seeking to purchase this compound can inquire through specialized chemical suppliers, ensuring they obtain a product that meets stringent purity and efficacy requirements for their critical work.